Skip to main content
. 2022 Feb 18;146(2):739–748. doi: 10.1093/brain/awac067

Figure 2.

Figure 2

GBS case rate within 6 weeks of first-dose of COVID-19 vaccination in England. Estimated rate of GBS cases within 6 weeks of first COVID-19 vaccination (per 100 000 doses) separated by (A) vaccine type, (B) age/gender, (C) age for ChAdOx1 nCoV-19 and tozinameran vaccines and (D) gender for ChAdOx1 nCoV-19 and tozinameran vaccines. Size of dots are weighted based on GBS case numbers. Crosses represent upper and lower limits of 95% CIs.